Andrew Kolodny

Dr. Andrew Kolodny is Senior Research Scientist II at Brandeis University's Institute for Behavioral Health and Medical Director of the Opioid Policy Research Collaborative. He serves as President of Physicians for Responsible Opioid Prescribing and is nationally recognized as a leading expert on the opioid epidemic, having advised U.S. Congressional committees, the Department of Justice, and state Attorneys General in investigations of the opioid industry.

Education:

• M.D. from Temple University
• B.A. from CUNY Queens College

His research focuses on public health interventions for the opioid crisis, specializing in buprenorphine treatment programs, naloxone overdose prevention, and emergency department-based screening for substance misuse. Dr. Kolodny has pioneered life-saving initiatives in New York City and shapes national policy through testimony before Congress on topics including "America's Addiction to Opioids" and "Combatting the Opioid Crisis," emphasizing evidence-based approaches to reduce opioid-related harm.

Scientific awards:

• No awards documented in source material

Dr. Kolodny's advisory work spans clinical program development and policy advocacy, with prior leadership as Chief Medical Officer of Phoenix House and Chair of Psychiatry at Maimonides Medical Center. His grant activities center on opioid policy research funded through academic channels.

He leads the Opioid Policy Research Collaborative, a multidisciplinary team generating evidence for effective opioid regulation and treatment protocols.